Balloon Catheter

This channel includes news and new technology innovations for angioplasty balloon catheters (PTA). These are used in arteries with atherosclerotic lesions to compress the plaque expand the artery lumen to reopen occluded or heavily stenosed atherosclerotic lesions. Balloons are often used in combination with a stent to prop the treated vessel segment open. In addition to plain old balloon angioplasty (POBA), this section includes news about drug-coated balloon (DCB), valvuloplasty balloons and specialty cutting balloon.

News | Drug-Eluting Balloons

October 10, 2019 — An independent analysis of Lutonix 035 drug-coated balloon (DCB) patient-level data showed no ...

Home October 10, 2019
Home
Videos | TCT

Chandan Devireddy, M.D., offers insights about what he saw as the top take aways from the 2019 Transcatheter ...

Home October 04, 2019
Home
News | Drug-Eluting Balloons

September 20, 2019 — Orchestra BioMed Inc., in partnership with Terumo Corp. announced the company has secured ...

Home September 20, 2019
Home
News | Peripheral Artery Disease (PAD)

August 27, 2019 — Concept Medical was recently granted Breakthrough Therapy designation by the U.S. Food and Drug ...

Home August 27, 2019
Home
News | Peripheral Artery Disease (PAD)

August 14, 2019 — Concept Medical Inc. (CMI) has been granted "Breakthrough Device Designation" from the U.S. Food and ...

Home August 14, 2019
Home
News | Drug-Eluting Balloons

August 2, 2019 — B. Braun Interventional Systems Inc. (BIS) announced the U.S. Food and Drug Administration (FDA) has ...

Home August 02, 2019
Home
News | Balloon Catheter

July 15, 2019 — Edwards LifeSciences is recalling the IntraClude Intra-Aortic Occlusion Device due to a risk of balloon ...

Home July 15, 2019
Home
News | Heart Failure

June 17, 2019 – Results from a first-in-man proof of concept study found occlusion of the superior vena cava (SVC) ...

Home June 17, 2019
Home
News | Drug-Eluting Balloons

June 13, 2019 — Orchestra BioMed Inc. announced it has formed a global strategic partnership with Terumo Corp. for ...

Home June 13, 2019
Home
News | Drug-Eluting Balloons

May 29, 2019 — Philips announced the three-year results from the ILLUMENATE Pivotal trial and the ILLUMENATE European ...

Home May 29, 2019
Home
News | Drug-Eluting Balloons

May 2, 2019 — Concept Medical Inc. (CMI) has been granted Breakthrough Device Designation from the U.S. Food and Drug ...

Home May 02, 2019
Home
News | Congenital Heart

April 29, 2019 — Edwards Lifesciences is recalling the Miller Balloon Atrioseptostomy Catheter and Fogarty Dilation ...

Home April 29, 2019
Home
Technology | Drug-Eluting Balloons

April 24, 2019 —  Orchestra BioMed Inc. has secured Breakthrough Device designation by the U.S. Food and Drug ...

Home April 24, 2019
Home
Angiography shows a stenotic lesion in the mid right coronary artery, undilatable by standard high-pressure balloon angioplasty (inset, arrowheads). (B) Optical coherence tomography (OCT) cross-sectional (top) and longitudinal (bottom) images acquired before IVL and coregistered to the OCT lens (arrow in A) demonstrate severe near-circumferential calcification in the area of the stenosis. (C) Angiography demonstrates improvement in the area of stenosis after IVL lithoplasty.
Feature | Cath Lab | Dean Kereiakes, M.D., FACC, FSCAI, and Jonathan Hill, M.D., DISRUPT CAD III Co-Principal Investigators

Over the last 40 years, despite multiple advancements in percutaneous coronary interventions, calcified lesions remain a ...

Home April 15, 2019
Home
News | Drug-Eluting Balloons

March 6, 2019 – Swiss-based M.A. MedAlliance SA has been granted Breakthrough Device Designation from the U.S. Food and ...

Home March 06, 2019
Home
Subscribe Now